Sham_vs_UIR — integMET

Profile details

Identifier: MTBLS3003_0001_00000001
Linked study: MTBLS3003 — Anti-anemia drug FG4592 retards the AKI to CKD transition by improving vascular regeneration and anti-oxidative capability (day 21)
Comparison: Sham vs UIR
Group A: Control group with no induced injury or treatment.. Provides a reference point for evaluating the effects of UIR and UIR+FG treatments.
Group B: Group with unilateral kidney ischemia-reperfusion (UIR) induced.. Allows assessment of the effects of UIR on kidney function and structure.
Total features tested: 88
Significant features: 22
p-value threshold: 0.05
Ratio threshold (upper): 1.5
Ratio threshold (lower): 1/1.5
Date created: 2025-09-26 00:00:00

Metabolite ID (InChI Key)	Name	Direction	Ratio	p-value
KRKNYBCHXYNGOX-UHFFFAOYSA-N	Citronensäure	down	0.03965	2.98e-05
LEHOTFFKMJEONL-UHFFFAOYSA-N	1H-purine-2,6,8-triol	down	0.1633	8.84e-05
MYHXHCUNDDAEOZ-FOSBLDSVSA-N	Prostaglandin A2	down	0.2708	0.000216
SUHOOTKUPISOBE-UHFFFAOYSA-N	colamine phosphate	down	0.214	0.00241
CDAISMWEOUEBRE-GPIVLXJGSA-N	D-myo-Inositol	down	0.3415	0.000607
OSJPPGNTCRNQQC-UWTATZPHSA-N	3-Phospho-D-glycerate	up	4.716	0.00608
HEBKCHPVOIAQTA-QWWZWVQMSA-N	D-Arabinitol	up	3.118	0.00326
FJKROLUGYXJWQN-UHFFFAOYSA-N	<em>p</em>-salicylic acid	up	4.066	0.0117
FMGSKLZLMKYGDP-USOAJAOKSA-N	Prasterone	up	5.59	0.0382
UQZIYBXSHAGNOE-XNSRJBNMSA-N	Stachyose	down	0.1853	0.0367